What does target price mean in stocks?
Target Price in Stocks
- Target Price Advantage. A target price is an estimate of where an analyst thinks a stock will go. ...
- Target Price Disadvantage. The analysts could be wrong. ...
- Advantage of Starting from the Actual Price. ...
- Disadvantage of Starting from the Actual Price. ...
How much are target stocks?
Target stock price target raised to $353 from $305 at Deutsche Bank Mar. 2, 2022 at 7:53 a.m. ET by Tomi Kilgore Target stock price target raised to $290 from $262 at J.P. Morgan
What is the price of target stock?
The target stock price is an estimate that an analyst believes will be the current price at some point in the future, generally 12 months from now. Price targets can give you an indication of what others believe a stock is truly worth.
What is target stock price?
$350 Price Target for Nvidia Stock Is Ambitious But Possible
- Nvidia ( NVDA) will face headwinds, no doubt, but the company remains a tech-market leader and innovator.
- Two Wall Street experts are preparing for Nvidia stock to move higher.
- Investors should buy some Nvidia shares on the dip.
See more
Is Acrx a good stock to buy?
According to the issued ratings of 2 analysts in the last year, the consensus rating for AcelRx Pharmaceuticals stock is Moderate Buy based on the current 1 hold rating and 1 buy rating for ACRX.
Will Acrx go up?
AcelRx Pharmaceuticals Inc (NASDAQ:ACRX) The 1 analysts offering 12-month price forecasts for AcelRx Pharmaceuticals Inc have a median target of 4.00, with a high estimate of 4.00 and a low estimate of 4.00. The median estimate represents a +1,493.63% increase from the last price of 0.25.
Who owns Acelrx Pharmaceuticals Inc?
from 2002 until the acquisition of the company by Abbott Laboratories in December 2006. During his tenure he led the transformation of Kos into a fully integrated and profitable pharmaceutical company with annual revenues approaching $1 billion.
Should I buy or sell AcelRx Pharmaceuticals stock right now?
2 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for AcelRx Pharmaceuticals in the last year. There are currently 1 ho...
What is AcelRx Pharmaceuticals' stock price forecast for 2022?
2 equities research analysts have issued 12-month price objectives for AcelRx Pharmaceuticals' stock. Their forecasts range from $5.00 to $5.00. On...
How has AcelRx Pharmaceuticals' stock performed in 2022?
AcelRx Pharmaceuticals' stock was trading at $0.56 at the beginning of the year. Since then, ACRX stock has decreased by 63.1% and is now trading a...
Are investors shorting AcelRx Pharmaceuticals?
AcelRx Pharmaceuticals saw a increase in short interest in May. As of May 31st, there was short interest totaling 3,790,000 shares, an increase of...
When is AcelRx Pharmaceuticals' next earnings date?
AcelRx Pharmaceuticals is scheduled to release its next quarterly earnings announcement on Monday, August 15th 2022. View our earnings forecast fo...
How were AcelRx Pharmaceuticals' earnings last quarter?
AcelRx Pharmaceuticals, Inc. (NASDAQ:ACRX) posted its quarterly earnings results on Monday, May, 16th. The specialty pharmaceutical company reporte...
Who are AcelRx Pharmaceuticals' key executives?
AcelRx Pharmaceuticals' management team includes the following people: Mr. Vincent J. Angotti , CEO & Director (Age 54, Pay $915.29k) Dr. Pamela...
Who are some of AcelRx Pharmaceuticals' key competitors?
Some companies that are related to AcelRx Pharmaceuticals include Actinium Pharmaceuticals (ATNM) , Actinium Pharmaceuticals (ATNM) , Homology M...
What other stocks do shareholders of AcelRx Pharmaceuticals own?
Based on aggregate information from My MarketBeat watchlists, some companies that other AcelRx Pharmaceuticals investors own include Advanced Micr...
What is the official website of Acelrx?
Who is Acelrx Pharmaceuticals?
The official website for AcelRx Pharmaceuticals is www.acelrx.com.
Is Acelrx a buy or sell company?
AcelRx Pharmaceuticals, Inc. engages in the development and commercialization of therapies use in medically supervised settings. The firm's portfolio includes DSUVIA, DZUVEO, Zalviso, ARX-02 and ARX-03. The company was founded by Thomas A. Schreck and Pamela Pierce Palmer on July 13, 2005 and is headquartered in Redwood City, CA.
Does Acelrx pay dividends?
AcelRx Pharmaceuticals has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 1 buy rating, no hold ratings, and no sell ratings.
Pre-Market Trades
AcelRx Pharmaceuticals does not currently pay a dividend.
About Pre-Market Quotes
Investors may trade in the Pre-Market (4:00-9:30 a.m. ET) and the After Hours Market (4:00-8:00 p.m. ET). Participation from Market Makers and ECNs is strictly voluntary and as a result, these sessions may offer less liquidity and inferior prices. Stock prices may also move more quickly in this environment.
